发布时间：2008.1

摘要

Countries covered: Global

This  research service titled Global Immunochemicals Markets assesses the global market opportunities for immunochemicals, particularly in terms of the market potential, competitive landscape and market attractiveness for research antibodies in the US, European, Japanese and Rest-of-World markets. The study takes into account immunochemicals, which include the following commercially produced antibodies for research purposes: polyclonal antibodies, monoclonal antibodies and conjugated antibodies.

This research service is available through our Pharmaceuticals & Biotechnology Growth Partnership Services programme. With this programme you receive industry-leading market research such as this, along with technical and econometric data and many interactive features including Analyst Inquiry Time and Client Councils.

Market Overview

Diverse Application Range Supports Market Development

Antibodies have found immense use in drug discovery and research owing to their diversity coupled with high specificity of antibody-antigen interactions. These characteristics have been found to be very useful in unraveling the details of biological systems. Antibodies have found applications as research tools and assay components. In addition, they have been deployed as drug delivery vehicles, diagnostics, imaging and therapeutics. "The mounting demand for cancer research has been a crucial driving factor for the immunochemicals market globally," notes the analyst of this research. "Research antibodies have been used as tools in various applications including signalling pathways, measuring the modifications or expression levels of cancer-related proteins, identifying candidate biomarkers, profiling proteins and measuring enzyme activity."

Expanding research in agriculture and bio-terrorism is boosting demand for research antibodies. Proteome research and the genome project will create growth opportunities with the discovery of newer proteins motivating manufacturers to augment their store of novel antibodies. Custom antibodies are gaining importance due to proteome research. At the same time, proteome research has given rise to many new antibody targets, while creating new challenges for market participants who will have to revamp their stocks to accommodate these novel antibodies. In addition, producing novel antibodies is time consuming and therefore, impacts business activities.

Creation of a Common Catalogue Key to Facilitating and Simplifying Uptake of Antibodies

In spite of being highly fragmented with over 300 active companies, the immunochemicals market is dynamic and evolving. The industry appears to be entering a new phase. On the competitive front, fierce rivalries have led to competitive pricing and low revenue generation. Market shares are being diluted leaving the market landscape more open to mergers. The future is likely to witness substantial restructuring and consolidation activity.

A key challenge pertains to the profusion of antibodies; researchers are unable to browse through the enormous number of companies and their offerings to acquire their desired antibodies. The large selection of antibodies available makes it difficult for researchers to review and identify the most suitable antibody for their use. "The introduction of a common catalogue providing details about various companies, products, offers, prices and contacts would be ideal in widening the customer base," advises the analyst. "This strategy would facilitate the use of research antibodies and boost market revenues."

目录及图表

1. Executive Summary

1. Executive Summary of the Global Immunochemicals Market

1. Overview of the Global Immunochemicals market

2. Introduction

1. Methodology for the Global Immunochemicals Market

1. Research Methodology

2. Scope and Objectives

3. Key Definitions

3. Industry Challenges

1. Industry Challenges for the Global Immunochemicals Market

1. Major Industry Challenges

4. Market Engineering Research

1. Market Engineering Research for the Global Immunochemicals Market

1. Market Overview

2. Market Engineering Measurements

3. Market Drivers

a. Increasing Demand for Research in Medical (Especially Oncology) Agriculture and Bio-terrorism

b. Advances in Antibody Technology

c. Human Genome Project and Proteome Research

d. Low Risk Market So Low Barriers of Entry

4. Market Restraints

a. Low Pricing Scenario Deters Distributors to Enter the ROW Market

b. Downsizing of Research Departments in Both Pharmaceutical and Biotech Industries

c. Import Tax on Research Products (In ROW)

d. Limited Financial Budgets for Academic Researchers (Especially in ROW)

e. Focus on Areas Like Terrorism Restricts the Budget for Life Sciences Research in the U.S. Market

f. Mergers Among Companies Diminish Sales Potential

g. Strong € and Weak $ and ¥ Restrain Market Growth

5. Market Trends and End-user Analysis

6. Competitive Landscape

7. Revenue Forecasts

5. Strategic Recommendations

1. Market Engineering Recommendations

1. Strategic Recommendations for the Global Immunochemicals Market

6. Database of Key Industry Participants

1. Key Industry Participants

1. Major Participants

7. Appendix

1. Decision Support Database

1. Total Healthcare Expenditure

2. Pharmaceutical R&D Expenditures

3. Percent Pharmaceutical R&D Expernditures

4. Private Healthcare Expenditures

5. Per Capita Healthcare Expenditures

List of Figures

Chapter 3

Immunochemicals Market: Impact of Top Industry Challenges (World), 2008 to 2014

Chapter 4

Immunochemicals Market: Market Drivers Ranked in Order of Impact (World), 2008-2014

Immunochemicals Market: Market Restraints Ranked in Order of Impact (World), 2008-2014

Immunochemicals Market: Competitive Structure (World), 2007

Immunochemicals Market: Highlights of Some Consolidations Witnessed (World), 2005, 2006 and 2007

Immunochemicals Market: Revenue Forecasts (World), 2004-2014

Immunochemicals Market: Revenue Forecasts (United States), 2004-2014

Immunochemicals Market: Revenue Forecasts (Europe), 2004-2014

Immunochemicals Market: Revenue Forecasts (Japan), 2004-2014

Immunochemicals Market: Revenue Forecasts (Rest-of-World), 2004-2014

Chapter 7

Decision Support Database: Total Healthcare Expenditure in Billion USD (World), 1999-2006

Decision Support Database: Pharmaceutical R&D Expenditure in Million USD (World), 1999-2006

Decision Support Database: Pharmaceutical R&D Expenditure as a Percentage of Pharmaceutical Market (World), 1999-2006

Decision Support Database: Private Healthcare Expenditure in Billion USD (World), 1999-2006

Decision Support Database: Per capita Healthcare Expenditure in USD (World), 1999-2006